🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of a Computerized Cognitive Stimulation Intervention Adapted to the Level of Cognitive Reserve

RecruitingNAAges 60 Years - anyAllUniversidad de Zaragoza
NCT06279325 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Normal ageing presents subtle cognitive changes that can be detected before meeting the criteria for Mild cognitive impairment (MCI). Older people with low cognitive reserve and who receive limited cognitive stimulation are at greater risk of deterioration. In this regard, cognitive stimulation (CS) has been identified as an intervention that reduces this risk, provided that its design considers the differences in the level of cognitive reserve (CR) acquired throughout life and the baseline level of cognitive functioning. The general objective of this study is to evaluate, through a randomized clinical trial, the effectiveness of a computerized cognitive stimulation program, designed and adapted from Occupational Therapy based on the level of cognitive reserve in older adults in Primary Care. 100 participants will be randomized in a stratified manner according to the level of cognitive r

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age: ≥ 60 years. * With score in Lobo's Mini-cognitive Examination (MEC-35) (Lobo, A., Escolar, V., Ezquerra, J., \& Seva Díaz, 1979) between: 28-35 points (Friedman et al., 2012; Vinyoles Bargalló et al., 2002). * Non-institutionalized persons, belonging to the health centers where the study was conducted. * With a minimum educational level (knowing how to read and write). * Who do not present hearing, visual or communication difficulties that would prevent them from completing the cognitive training. Exclusion Criteria: * People with mild cognitive impairment or Alzheimer's disease (AD). * People with significant functional impairment. * People who have received any type of professionalized cognitive stimulation therapy in the last year. * People with significant psychiatric conditions, such as major depressive disorder or schizophrenia. * People who are taking medications that may adversely affect cognitive function, such as anticholinergics, tranquilizers and anticonvulsants.
💊

What it tests

  • Computerized cognitive stimulation program
  • Face-to-face training-explanatory session
📍

Where

1 site
Centro de Salud Arrabal
Zaragoza, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy